Banerjee D - Search Results

1

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Xie X, Kerrigan JE, Minko T, Garbuzenko O, Lee KC, Scarborough A, Abali EE, Budak-Alpdogan T, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Among authors: banerjee d. Cancer Biol Ther. 2013 Aug;14(8):742-51. doi: 10.4161/cbt.25184. Epub 2013 Jun 3. Cancer Biol Ther. 2013. PMID: 23792570 Free PMC article.

2

Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification.

Iwamoto M, Banerjee D, Menon LG, Jurkiewicz A, Rao PH, Kemeny NE, Fong Y, Jhanwar SC, Gorlick R, Bertino JR. Iwamoto M, et al. Among authors: banerjee d. Cancer Biol Ther. 2004 Apr;3(4):395-9. Epub 2004 Apr 29. Cancer Biol Ther. 2004. PMID: 14726656

3

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.

Barboza NM, Medina DJ, Budak-Alpdogan T, Aracil M, Jimeno JM, Bertino JR, Banerjee D. Barboza NM, et al. Among authors: banerjee d. Cancer Biol Ther. 2012 Jan 15;13(2):114-22. doi: 10.4161/cbt.13.2.18876. Cancer Biol Ther. 2012. PMID: 22336911 Free PMC article.

4

A second target of benzamide riboside: dihydrofolate reductase.

Roussel B, Johnson-Farley N, Kerrigan JE, Scotto KW, Banerjee D, Felczak K, Pankiewicz KW, Gounder M, Lin H, Abali EE, Bertino JR. Roussel B, et al. Among authors: banerjee d. Cancer Biol Ther. 2012 Nov;13(13):1290-8. doi: 10.4161/cbt.21786. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954684 Free PMC article.

5

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.

Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Among authors: banerjee d. Oncotarget. 2014 Feb 28;5(4):901-7. doi: 10.18632/oncotarget.1809. Oncotarget. 2014. PMID: 24658650 Free PMC article.

6

Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.

Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Shaik T, et al. Among authors: banerjee d. Oncotarget. 2018 Sep 7;9(70):33249-33257. doi: 10.18632/oncotarget.26064. eCollection 2018 Sep 7. Oncotarget. 2018. PMID: 30279956 Free PMC article.

7

Thymidylate synthase as an oncogene?

Bertino JR, Banerjee D. Bertino JR, et al. Among authors: banerjee d. Cancer Cell. 2004 Apr;5(4):301-2. doi: 10.1016/s1535-6108(04)00086-8. Cancer Cell. 2004. PMID: 15093534 Free article.

8

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Takahashi N, et al. Among authors: banerjee d. Cancer Res. 2002 Dec 1;62(23):6909-15. Cancer Res. 2002. PMID: 12460906

9

Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?

Bertino JR, Banerjee D. Bertino JR, et al. Among authors: banerjee d. Clin Cancer Res. 2003 Apr;9(4):1235-9. Clin Cancer Res. 2003. PMID: 12684389 Review. No abstract available.

10

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Budak-Alpdogan T, et al. Among authors: banerjee d. Mol Ther. 2004 Sep;10(3):574-84. doi: 10.1016/j.ymthe.2004.06.115. Mol Ther. 2004. PMID: 15336657 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,915 results

Search Page